Evidence map›Paper›PMID 18971483›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2008

Requirement of 3-phosphoinositide-dependent protein kinase-1 for BDNF-mediated neuronal survival.

Giorgi Kharebava, Denys Makonchuk, Katarzyna B Kalita, Jing-Juan Zheng, Michal Hetman

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Ras family small GTPase-mediated neuroprotective signaling in stroke.Central nervous system agents in medicinal chemistry · 2011
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Giorgi KharebavaKentucky Spinal Cord Injury Research Center, University of Louisville, Louisville, Kentucky 40292, USA.
Denys Makonchuk
Katarzyna B Kalita
Jing-Juan Zheng
Michal Hetman
Neurological Surgery · USInstytut Biologii Doświadczalnej im. Marcelego Nenckiego · PLUniversity of Louisville · USUniversity of Louisville Hospital · US

Funding

Signaling pathways in neuronal susceptibility to hypoxiaP20RR015576 · NCRR · UNIVERSITY OF LOUISVILLE · PI GOZAL, EVELYNE · 2000 to 2009
$18.5M
Survival signaling in CNS neurons exposed to DNA damageR01NS047341 · NINDS · UNIVERSITY OF LOUISVILLE · PI HETMAN, MICHAL · 2004 to 2008
$1.3M
NCRR NIH HHS P20 RR015576NCRR NIH HHS RR015576-06NINDS NIH HHS NS047341-01NINDS NIH HHS R01 NS047341
6 · The paper itself

Abstract

Although PDK1 regulates several signaling pathways that respond to neurotrophins, direct evidence for its involvement in neurotrophin-mediated survival has not yet been reported. Here we show high neuronal expression of active PDK1 in the rat cortex and hippocampus at the developmental stages with pronounced dependence on extracellular survival signals. Also, in cultured cortical neurons from newborn rats, BDNF resulted in PDK1- and extracellular signal-regulated kinase-1/2 (ERK1/2)-mediated activation of their direct target, the p90 ribosomal S6 kinase 1/2 (RSK1/2). In trophic-deprived cortical neurons, knockdown of endogenous PDK1 attenuated the antiapoptotic survival response to 10 ng/ml BDNF, whereas an overexpressed active mutant form of PDK1 reduced apoptosis. The neuroprotection by BDNF or active PDK1 required RSK1/2. Conversely, PDK1 knockdown reversed the survival effects of combining the overexpressed RSK1 with a low, subprotective BDNF concentration of 2 ng/ml. Likewise, the protection by the overexpressed, active PDK1 was enhanced by coexpression of an active RSK1 mutant. Consistent with the observations that in BDNF-stimulated neurons RSK1/2 activation required both PDK1 and ERK1/2, ERK1/2 knockdown removed BDNF-mediated survival. Selective activation of ERK1/2 with an overexpressed active mutant form of MKK1 resulted in RSK1/2- and PDK1-dependent neuroprotection. Finally, at subprotective plasmid DNA dosage, overexpression of the active MKK1 and PDK1 mutants produced synergistic effect on survival. Our findings indicate a critical role for PDK1-RSK1/2 signaling in BDNF-mediated neuronal survival. Thus, the PDK1 is indispensable for the antiapoptotic effects of the ERK1/2 pathway offering previously unrecognized layer of survival signal processing and integration.

Indexed as

3-Phosphoinositide-Dependent Protein KinasesAnimalsBrain-Derived Neurotrophic FactorCells, CulturedCell SurvivalHumansMiceNeuronsProtein Serine-Threonine KinasesRats3-Phosphoinositide-Dependent Protein KinasesBrain-Derived Neurotrophic FactorPDPK1 protein, humanPdpk1 protein, mousePdpk1 protein, ratProtein Serine-Threonine Kinases

Identifiers

PMID18971483
PMCPMC3383049
OpenAlexW2074944370

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.